SBIR/STTR Research Award

Engineering Useful Type I restriction enzymes

Award identifier 6a1761e05f6cfebdaeb2ff58a3892b08926171a2318bd7c0b81c03a10a51b25bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$107,000

Program and phase

SBIR · Phase I

Award year

2007

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NEW ENGLAND BIOLABS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
EDKJNT8DADG8
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Restriction enzymes are essential laboratory tools for analyzing and cloning DNA. Two principal kinds exist in nature that differ in the way they cleave the substrate. Type II restriction enzymes cleave DNA at fixed positions with respect to their recognition sequences, producing fragments of defined length with predictable termini. These are the useful enzymes, familiar to molecular biologists everywhere. Type I enzymes cleave DNA at random with respect to their recognition sequences, producing fragments of variable length with unpredictable termini. These enzymes are not useful. We propose altering type I enzymes to make them cleave at fixed positions. This will be achieved by replacing the type I subunit that catalyzes random cleavage with a type IIG domain that catalyzes fixed cleavage. The altered enzymes should now cleave close to their recognition sequences, and as a result they should be useful. Since the sequences recognized by type I enzymes are determined by subunits that are modular and appear to be interchangeable, altering just a few enzymes could open the door to a very large number of new specificities, and lead to the fabrication of 'designer' enzymes whose specificities could be custom-tailored, ultimately, to a user's needs. This project will provide molecular biologists with an array of new enzymes for DNA analysis and dissection. The enzymes will be modular, and the DNA sequences to which they attach will change according to which modules are provided. By combining the right modules, sequences of choice might be targeted in living cells with sufficient accuracy to pave the way for gene surgery.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

40 SBIR/STTR records share this UEI (1994–2013). Reported award amounts total $12,787,343. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.